Mark Pruzanski Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Pruzanski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Pruzanski. Mark Pruzanski is CEO & President in INTERCEPT PHARMACEUTICALS INC ($ICPT) and President and CEO in INTERCEPT PHARMACEUTICALS INC ($ICPT).
Mark Pruzanski in INTERCEPT PHARMACEUTICALS, INC.
Trading Symbol: ICPTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Pruzanski: CEO & President, President and CEO
Holdings: 491,032 shares
Current Value: $55,766,504
Latest Transaction: Jan 07 2015
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark Pruzanski in INTERCEPT PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 07 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 176.49 | 461 | 81,360 | 491,032 | 491.5 K to 491 K (-0.09 %) |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 0.00 | 4,868 | 0 | 19,471 | |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 0.00 | 4,868 | 0 | 491,493 | 486.6 K to 491.5 K (+1.00 %) |
Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 10,000 | 86,667 | 146,628 | |
Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 262.46 | 500 | 131,231 | 479,909 | 480.4 K to 479.9 K (-0.10 %) |
Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 261.71 | 2,950 | 772,034 | 480,409 | 483.4 K to 480.4 K (-0.61 %) |
Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 260.68 | 3,166 | 825,300 | 483,359 | 486.5 K to 483.4 K (-0.65 %) |
Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 259.47 | 1,100 | 285,420 | 486,525 | 487.6 K to 486.5 K (-0.23 %) |
Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 257.96 | 400 | 103,184 | 487,625 | 488 K to 487.6 K (-0.08 %) |
Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 256.54 | 200 | 51,308 | 488,025 | 488.2 K to 488 K (-0.04 %) |
Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 255.30 | 300 | 76,589 | 488,225 | 488.5 K to 488.2 K (-0.06 %) |
Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 254.29 | 500 | 127,146 | 488,525 | 489 K to 488.5 K (-0.10 %) |
Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 252.90 | 300 | 75,870 | 489,025 | 489.3 K to 489 K (-0.06 %) |
Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 250.80 | 384 | 96,308 | 489,325 | 489.7 K to 489.3 K (-0.08 %) |
Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 249.69 | 100 | 24,969 | 489,709 | 489.8 K to 489.7 K (-0.02 %) |
Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 247.66 | 100 | 24,766 | 489,809 | 489.9 K to 489.8 K (-0.02 %) |
Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 10,000 | 86,667 | 489,909 | 479.9 K to 489.9 K (+2.08 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 10,000 | 86,667 | 156,628 | |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 0.00 | 4,867 | 0 | 24,339 | |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 234.94 | 200 | 46,987 | 479,909 | 480.1 K to 479.9 K (-0.04 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 233.74 | 100 | 23,374 | 480,109 | 480.2 K to 480.1 K (-0.02 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 232.15 | 300 | 69,645 | 480,209 | 480.5 K to 480.2 K (-0.06 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 231.31 | 700 | 161,920 | 480,509 | 481.2 K to 480.5 K (-0.15 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 230.30 | 600 | 138,181 | 481,209 | 481.8 K to 481.2 K (-0.12 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 229.30 | 1,750 | 401,272 | 481,809 | 483.6 K to 481.8 K (-0.36 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 228.45 | 3,500 | 799,579 | 483,559 | 487.1 K to 483.6 K (-0.72 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 227.64 | 1,450 | 330,082 | 487,059 | 488.5 K to 487.1 K (-0.30 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 226.53 | 1,400 | 317,147 | 488,509 | 489.9 K to 488.5 K (-0.29 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 10,000 | 86,667 | 489,909 | 479.9 K to 489.9 K (+2.08 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 0.00 | 4,867 | 0 | 479,909 | 475 K to 479.9 K (+1.02 %) |
Apr 15 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | A | 266.01 | 22,931 | 6,099,875 | 22,931 | |
Apr 15 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | A | 266.01 | 5,733 | 1,525,035 | 5,733 | |
Apr 15 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Grant | A | 0.00 | 4,699 | 0 | 439,865 | 435.2 K to 439.9 K (+1.08 %) |
Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 0.00 | 4,868 | 0 | 34,074 | |
Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 0.00 | 4,868 | 0 | 435,166 | 430.3 K to 435.2 K (+1.13 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 2.89 | 12,850 | 37,122 | 13,111 | |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Option Exercise | M | 2.89 | 8,653 | 24,998 | 0 | |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Gift | G | 0.00 | 7,840 | 0 | 430,298 | 438.1 K to 430.3 K (-1.79 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 2.89 | 12,850 | 37,122 | 438,138 | 425.3 K to 438.1 K (+3.02 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President and CEO | Buy | M | 2.89 | 8,653 | 24,998 | 425,288 | 416.6 K to 425.3 K (+2.08 %) |
Page: 1